47.20
price up icon3.40%   1.55
pre-market  시장 영업 전:  48.00   0.80   +1.69%
loading
전일 마감가:
$45.65
열려 있는:
$45.15
하루 거래량:
5.32M
Relative Volume:
1.87
시가총액:
$115.87B
수익:
$43.23B
순이익/손실:
$6.79B
주가수익비율:
11.75
EPS:
4.0174
순현금흐름:
$9.17B
1주 성능:
+0.68%
1개월 성능:
-4.61%
6개월 성능:
-14.89%
1년 성능:
-18.10%
1일 변동 폭
Value
$44.62
$47.22
1주일 범위
Value
$44.62
$47.22
52주 변동 폭
Value
$44.62
$60.12

사노피 ADR Stock (SNY) Company Profile

Name
명칭
Sanofi Adr
Name
전화
-
Name
주소
-
Name
직원
82,878
Name
트위터
@sanofi
Name
다음 수익 날짜
2024-10-25
Name
최신 SEC 제출 서류
Name
SNY's Discussions on Twitter

SNY을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - General icon
SNY
Sanofi Adr
47.20 111.25B 43.23B 6.79B 9.17B 4.0174
Drug Manufacturers - General icon
LLY
Lilly Eli Co
763.00 651.28B 53.26B 13.80B -50.20M 15.30
Drug Manufacturers - General icon
JNJ
Johnson Johnson
185.42 437.40B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
231.54 394.23B 58.33B 3.73B 18.24B 2.10
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
128.24 240.24B 53.40B 13.68B 16.89B 6.9231
Drug Manufacturers - General icon
MRK
Merck Co Inc
83.93 196.28B 63.43B 16.42B 14.72B 6.49

사노피 ADR Stock (SNY) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-09-08 업그레이드 Morgan Stanley Equal-Weight → Overweight
2025-09-02 업그레이드 Deutsche Bank Hold → Buy
2025-08-08 업그레이드 JP Morgan Neutral → Overweight
2025-04-15 개시 Exane BNP Paribas Outperform
2025-03-21 개시 Goldman Neutral
2025-01-30 업그레이드 Deutsche Bank Sell → Hold
2024-07-26 재확인 Argus Buy
2024-01-23 개시 Morgan Stanley Equal-Weight
2024-01-16 재개 UBS Buy
2023-12-05 다운그레이드 JP Morgan Overweight → Neutral
2023-10-30 다운그레이드 Stifel Buy → Hold
2023-09-06 업그레이드 Berenberg Hold → Buy
2023-07-14 개시 HSBC Securities Buy
2023-04-28 다운그레이드 Deutsche Bank Hold → Sell
2023-03-27 업그레이드 Barclays Equal Weight → Overweight
2022-12-13 재개 Morgan Stanley Overweight
2022-08-12 업그레이드 Deutsche Bank Sell → Hold
2022-08-09 다운그레이드 UBS Buy → Neutral
2022-05-23 개시 SVB Leerink Outperform
2021-09-27 업그레이드 SVB Leerink Mkt Perform → Outperform
2021-01-15 개시 Deutsche Bank Sell
2020-09-29 개시 Berenberg Hold
2020-03-17 업그레이드 Barclays Underweight → Equal Weight
2020-03-11 업그레이드 Goldman Neutral → Buy
2020-02-11 개시 SVB Leerink Mkt Perform
2020-01-06 업그레이드 JP Morgan Neutral → Overweight
2019-09-23 업그레이드 Guggenheim Neutral → Buy
2019-09-20 업그레이드 Morgan Stanley Equal-Weight → Overweight
2019-09-03 개시 Bernstein Outperform
2019-08-14 업그레이드 UBS Neutral → Buy
2018-12-11 업그레이드 Jefferies Hold → Buy
2018-11-01 업그레이드 Barclays Underweight → Equal Weight
2018-10-09 개시 Guggenheim Neutral
2018-09-10 업그레이드 BofA/Merrill Neutral → Buy
2018-08-10 업그레이드 Citigroup Neutral → Buy
2018-03-23 업그레이드 Liberum Hold → Buy
2018-01-23 다운그레이드 Barclays Equal Weight → Underweight
2017-12-06 다운그레이드 BofA/Merrill Buy → Neutral
2017-12-01 다운그레이드 Morgan Stanley Overweight → Underweight
2017-11-15 업그레이드 Barclays Underweight → Equal Weight
2017-08-30 업그레이드 HSBC Securities Reduce → Hold
모두보기

사노피 ADR 주식(SNY)의 최신 뉴스

pulisher
Sep 29, 2025

BostInno🗳️ Vote in Inno Madness round two | 💻 UKG announces layoffs - The Business Journals

Sep 29, 2025
pulisher
Sep 26, 2025

Sanofi Expands Insulin Savings Program To Cover All US Patients - Benzinga

Sep 26, 2025
pulisher
Sep 17, 2025

Sanofi Reports Early Brivekimig Data, Signals Strong Efficacy And Good Tolerability - Sahm

Sep 17, 2025
pulisher
Sep 16, 2025

AstraZeneca Puts Cambridge Expansion On Ice Adding Pressure On Starmer Ahead Of Trump Visit - Sahm

Sep 16, 2025
pulisher
Sep 12, 2025

Sanofi: Informations relatives au nombre de droits de vote et d'actions - GlobeNewswire Inc.

Sep 12, 2025
pulisher
Sep 10, 2025

Mandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS® - Ariva

Sep 10, 2025
pulisher
Sep 04, 2025

What's Going On With Nektar Therapeutics Stock On Thursday? - Sahm

Sep 04, 2025
pulisher
Sep 04, 2025

Why Is Sanofi Stock Falling Thursday? - Sahm

Sep 04, 2025
pulisher
Sep 04, 2025

Sanofi Hit With Shock As Flagship Drug Successor Disappoints Investors - Sahm

Sep 04, 2025
pulisher
Aug 26, 2025

New Report Highlights Community Health Workers' Impact, Calls for Sustained Local Investment, During National CHW Awareness Week - Ariva

Aug 26, 2025
pulisher
Aug 21, 2025

European ADRs Under Pressure: Sector Divergence and Strategic Entry Points - AInvest

Aug 21, 2025
pulisher
Aug 05, 2025

Dupixent Leads the Charge for Sanofi's Strong Portfolio in Immunology, Vaccines, and Rare Diseases - Morningstar

Aug 05, 2025
pulisher
Aug 05, 2025

Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2025 Commentary - Seeking Alpha

Aug 05, 2025
pulisher
Jul 31, 2025

Sanofi ADR (SNY) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

Jul 31, 2025
pulisher
Jul 31, 2025

Sanofi ADR earnings beat by $0.63, revenue fell short of estimates - Investing.com Nigeria

Jul 31, 2025
pulisher
Jul 27, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SanofiSNY - cnhinews.com

Jul 27, 2025
pulisher
Jul 24, 2025

Sanofi: Reassessing Our Moat Rating for This Leader in Immunology, Vaccines, and Rare Diseases - Morningstar

Jul 24, 2025
pulisher
Jul 22, 2025

BEYFORTUS® reduced hospital and doctor visits for RSV disease in babies by 87%, according to largest US real-world study - Ariva

Jul 22, 2025
pulisher
Jul 21, 2025

AstraZeneca pledges $50 bln investment in US as pharma tariffs loom By Investing.com - Investing.com

Jul 21, 2025
pulisher
Jul 14, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SanofiSNY - FinancialContent

Jul 14, 2025
pulisher
Jul 01, 2025

Adagene stock gains as Sanofi expands agreement (ADAG:NASDAQ) - Seeking Alpha

Jul 01, 2025

사노피 ADR (SNY) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$111.00
price down icon 1.44%
drug_manufacturers_general PFE
$25.48
price up icon 6.83%
$282.20
price up icon 3.00%
drug_manufacturers_general NVO
$55.49
price down icon 0.02%
drug_manufacturers_general MRK
$83.93
price up icon 6.81%
자본화:     |  볼륨(24시간):